Sangamo Therapeutics (SGMO) – Analyst Ratings
-
Sangamo BioSciences (SGMO) PT Raised to $5 at H.C. Wainwright on positive outlook for the SIFTER platform
-
Truist Securities Downgrades Sangamo BioSciences (SGMO) to Hold, 'near-term financial/pipeline headwinds'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SGMO Stock Lookup